Staphylococcus aureus sigma B-dependent emergence of small-colony variants and biofilm production following exposure to Pseudomonas aeruginosa 4-hydroxy-2-heptylquinoline-N-oxide.

PubWeight™: 1.16‹?› | Rank: Top 10%

🔗 View Article (PMC 2824698)

Published in BMC Microbiol on January 30, 2010

Authors

Gabriel Mitchell1, David Lalonde Séguin, Ann-Elise Asselin, Eric Déziel, André M Cantin, Eric H Frost, Sophie Michaud, François Malouin

Author Affiliations

1: Centre d'Etude et de Valorisation de la Diversité Microbienne (CEVDM), Département de Biologie, Faculté des Sciences, Université de Sherbrooke, Sherbrooke, QC J1K2R1, Canada.

Articles citing this

Clinical significance of microbial infection and adaptation in cystic fibrosis. Clin Microbiol Rev (2011) 2.23

Staphylococcus aureus phenotype switching: an effective bacterial strategy to escape host immune response and establish a chronic infection. EMBO Mol Med (2011) 2.15

Auto Poisoning of the Respiratory Chain by a Quorum-Sensing-Regulated Molecule Favors Biofilm Formation and Antibiotic Tolerance. Curr Biol (2016) 1.46

Interactions of methicillin resistant Staphylococcus aureus USA300 and Pseudomonas aeruginosa in polymicrobial wound infection. PLoS One (2013) 1.32

Adaptive evolution of Staphylococcus aureus during chronic endobronchial infection of a cystic fibrosis patient. PLoS One (2011) 1.17

Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model. J Bacteriol (2015) 1.13

Targeting agr- and agr-Like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors (Basel) (2013) 1.01

Sigma Factor SigB Is Crucial to Mediate Staphylococcus aureus Adaptation during Chronic Infections. PLoS Pathog (2015) 0.97

Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome. ISME J (2015) 0.93

SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One (2013) 0.90

Staphylococcus aureus dynamically adapts global regulators and virulence factor expression in the course from acute to chronic infection. Curr Genet (2015) 0.90

Interspecific small molecule interactions between clinical isolates of Pseudomonas aeruginosa and Staphylococcus aureus from adult cystic fibrosis patients. PLoS One (2014) 0.89

Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother (2011) 0.87

Production of Pseudomonas aeruginosa Intercellular Small Signaling Molecules in Human Burn Wounds. J Pathog (2011) 0.86

Pseudomonas aeruginosa induces pigment production and enhances virulence in a white phenotypic variant of Staphylococcus aureus. Infect Drug Resist (2013) 0.84

Evolution of metabolic divergence in Pseudomonas aeruginosa during long-term infection facilitates a proto-cooperative interspecies interaction. ISME J (2015) 0.84

A Winogradsky-based culture system shows an association between microbial fermentation and cystic fibrosis exacerbation. ISME J (2015) 0.84

Staphylococcus aureus adapts to oxidative stress by producing H2O2-resistant small-colony variants via the SOS response. Infect Immun (2015) 0.82

Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB. Infect Immun (2011) 0.82

Novel Pathways for Ameliorating the Fitness Cost of Gentamicin Resistant Small Colony Variants. Front Microbiol (2016) 0.77

Phenotypic and Genotypic Characteristics of Small Colony Variants and Their Role in Chronic Infection. Microbiol Insights (2015) 0.77

Parallel Evolution in Streptococcus pneumoniae Biofilms. Genome Biol Evol (2016) 0.76

Ecological networking of cystic fibrosis lung infections. NPJ Biofilms Microbiomes (2016) 0.76

In vitro Multi-Species Biofilms of Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa and Their Host Interaction during In vivo Colonization of an Otitis Media Rat Model. Front Cell Infect Microbiol (2017) 0.75

Pseudomonas aeruginosa in premise plumbing of large buildings. Microbiologyopen (2016) 0.75

Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions. Antimicrob Agents Chemother (2015) 0.75

In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. Front Cell Infect Microbiol (2017) 0.75

Strong incidence of Pseudomonas aeruginosa on bacterial rrs and ITS genetic structures of cystic fibrosis sputa. PLoS One (2017) 0.75

Pseudomonas aeruginosa DesB Promotes Staphylococcus aureus Growth Inhibition in Coculture by Controlling the Synthesis of HAQs. PLoS One (2015) 0.75

An aroD Ochre Mutation Results in a Staphylococcus aureus Small Colony Variant That Can Undergo Phenotypic Switching via Two Alternative Mechanisms. Front Microbiol (2017) 0.75

Articles cited by this

Common virulence factors for bacterial pathogenicity in plants and animals. Science (1995) 11.22

Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol (2003) 10.68

Biofilms as complex differentiated communities. Annu Rev Microbiol (2002) 9.31

Lung infections associated with cystic fibrosis. Clin Microbiol Rev (2002) 9.20

Genetics of Pseudomonas. Bacteriol Rev (1969) 6.91

sigmaB modulates virulence determinant expression and stress resistance: characterization of a functional rsbU strain derived from Staphylococcus aureus 8325-4. J Bacteriol (2002) 6.71

Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat Rev Microbiol (2006) 5.73

Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov (2003) 5.48

Quorum sensing in staphylococci. Annu Rev Genet (2008) 4.58

Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J Bacteriol (2002) 4.04

Functions required for extracellular quinolone signaling by Pseudomonas aeruginosa. J Bacteriol (2002) 3.91

Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog (2008) 3.91

Mutation of sarA in Staphylococcus aureus limits biofilm formation. Infect Immun (2003) 3.77

Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis. J Infect Dis (1998) 3.61

Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbiol (2002) 3.57

Microarray-based analysis of the Staphylococcus aureus sigmaB regulon. J Bacteriol (2004) 3.45

Analysis of Pseudomonas aeruginosa 4-hydroxy-2-alkylquinolines (HAQs) reveals a role for 4-hydroxy-2-heptylquinoline in cell-to-cell communication. Proc Natl Acad Sci U S A (2004) 3.30

Inhibition of cytochrome systems of heart muscle and certain bacteria by the antagonists of dihydrostreptomycin: 2-alkyl-4-hydroxyquinoline N-oxides. Biochem J (1956) 3.26

Modulation of Pseudomonas aeruginosa gene expression by host microflora through interspecies communication. Mol Microbiol (2003) 3.09

ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett (2007) 3.01

Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol Rev (2004) 3.01

New method for typing Staphylococcus aureus strains: multiple-locus variable-number tandem repeat analysis of polymorphism and genetic relationships of clinical isolates. J Clin Microbiol (2003) 2.96

Alternative transcription factor sigma(B) is involved in regulation of biofilm expression in a Staphylococcus aureus mucosal isolate. J Bacteriol (2000) 2.78

Microbial ecology of the cystic fibrosis lung. Microbiology (2007) 2.68

N-acylhomoserine-lactone-mediated communication between Pseudomonas aeruginosa and Burkholderia cepacia in mixed biofilms. Microbiology (2001) 2.51

A novel Staphylococcus aureus biofilm phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. J Bacteriol (2008) 2.51

Alternative transcription factor sigmaSB of Staphylococcus aureus: characterization and role in transcription of the global regulatory locus sar. J Bacteriol (1997) 2.45

Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol (2009) 2.38

Human polymicrobial infections. Lancet (2005) 2.34

agr function in clinical Staphylococcus aureus isolates. Microbiology (2008) 2.33

Prevalence of agr dysfunction among colonizing Staphylococcus aureus strains. J Infect Dis (2008) 2.29

Fibronectin binding protein and host cell tyrosine kinase are required for internalization of Staphylococcus aureus by epithelial cells. Infect Immun (1999) 2.28

Increased expression of clumping factor and fibronectin-binding proteins by hemB mutants of Staphylococcus aureus expressing small colony variant phenotypes. Infect Immun (2002) 2.08

Diffusible signals and interspecies communication in bacteria. Microbiology (2008) 2.05

Staphylococcus aureus serves as an iron source for Pseudomonas aeruginosa during in vivo coculture. J Bacteriol (2005) 2.04

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.95

Interconnections between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm maturation. Infect Immun (2009) 1.86

Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa. J Am Soc Mass Spectrom (2004) 1.85

Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front Biosci (2002) 1.73

2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J Antimicrob Chemother (1992) 1.71

Dynorphin activates quorum sensing quinolone signaling in Pseudomonas aeruginosa. PLoS Pathog (2007) 1.60

Synthesis of multiple N-acylhomoserine lactones is wide-spread among the members of the Burkholderia cepacia complex. Syst Appl Microbiol (2001) 1.54

Phenotypic switching of antibiotic resistance circumvents permanent costs in Staphylococcus aureus. Curr Biol (2001) 1.48

Mutations are involved in emergence of aminoglycoside-induced small colony variants of Staphylococcus aureus. Int J Med Microbiol (2003) 1.48

Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog (1988) 1.46

Prevalence and clinical significance of Staphylococcus aureus small-colony variants in cystic fibrosis lung disease. J Clin Microbiol (2006) 1.45

Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J Med Microbiol (2009) 1.43

N-acylhomoserine lactones antagonize virulence gene expression and quorum sensing in Staphylococcus aureus. Infect Immun (2006) 1.35

Thymidine-dependent Staphylococcus aureus small-colony variants are associated with extensive alterations in regulator and virulence gene expression profiles. Infect Immun (2005) 1.35

Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J Bacteriol (2008) 1.27

Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants. FEMS Immunol Med Microbiol (2002) 1.27

Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol (2006) 1.20

Factors influencing the internalization of Staphylococcus aureus and impacts on the course of infections in humans. Appl Microbiol Biotechnol (2001) 1.18

Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa. Appl Environ Microbiol (2009) 1.16

Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol Med Microbiol (2004) 1.13

Burkholderia spp. alter Pseudomonas aeruginosa physiology through iron sequestration. J Bacteriol (2004) 1.13

A defect in menadione biosynthesis induces global changes in gene expression in Staphylococcus aureus. J Bacteriol (2008) 1.07

Role of sigmaB in the expression of Staphylococcus aureus cell wall adhesins ClfA and FnbA and contribution to infectivity in a rat model of experimental endocarditis. Infect Immun (2005) 1.02

Genetic evidence for an alternative citrate-dependent biofilm formation pathway in Staphylococcus aureus that is dependent on fibronectin binding proteins and the GraRS two-component regulatory system. Infect Immun (2008) 1.01

Natural human isolates of Staphylococcus aureus selected for high production of proteases and alpha-hemolysin are sigmaB deficient. Int J Med Microbiol (2006) 0.99

A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb Pathog (2009) 0.98

Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog Dis (2008) 0.97

Staphylococcus aureus SigB activity promotes a strong fibronectin-bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol Microbiol (2008) 0.96

Molecular characterization of regulatory genes associated with biofilm variation in a Staphylococcus aureus strain. J Microbiol Biotechnol (2008) 0.90

Changes in the agr locus affect enteritis caused by methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2009) 0.82

Recurrent upper airway infections and bacterial biofilms. J Laryngol Otol (2006) 0.80

Articles by these authors

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med (2005) 16.59

Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med (2011) 4.62

Genomic analysis reveals that Pseudomonas aeruginosa virulence is combinatorial. Genome Biol (2006) 3.75

Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol (2007) 3.60

The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci U S A (2004) 3.01

Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol (2003) 2.89

Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol (2007) 2.87

Bacterial c-di-GMP is an immunostimulatory molecule. J Immunol (2007) 2.13

MvfR, a key Pseudomonas aeruginosa pathogenicity LTTR-class regulatory protein, has dual ligands. Mol Microbiol (2006) 2.12

Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A (2006) 1.95

High-dose ibuprofen in cystic fibrosis: Canadian safety and effectiveness trial. J Pediatr (2007) 1.86

Electrospray/mass spectrometric identification and analysis of 4-hydroxy-2-alkylquinolines (HAQs) produced by Pseudomonas aeruginosa. J Am Soc Mass Spectrom (2004) 1.85

Revisiting the quorum-sensing hierarchy in Pseudomonas aeruginosa: the transcriptional regulator RhlR regulates LasR-specific factors. Microbiology (2009) 1.74

Production of rhamnolipids by Pseudomonas aeruginosa. Appl Microbiol Biotechnol (2005) 1.70

Binding of ceftaroline to penicillin-binding proteins of Staphylococcus aureus and Streptococcus pneumoniae. J Antimicrob Chemother (2010) 1.65

Macrolide resistance in Campylobacter jejuni and Campylobacter coli: molecular mechanism and stability of the resistance phenotype. Antimicrob Agents Chemother (2005) 1.64

Rhamnolipids: diversity of structures, microbial origins and roles. Appl Microbiol Biotechnol (2010) 1.62

Self-produced extracellular stimuli modulate the Pseudomonas aeruginosa swarming motility behaviour. Environ Microbiol (2007) 1.59

Clostridium difficile: a formidable foe. CMAJ (2004) 1.54

Pseudomonas aeruginosa-plant root interactions. Pathogenicity, biofilm formation, and root exudation. Plant Physiol (2003) 1.50

Multilocus sequence typing of Campylobacter jejuni isolates from humans, chickens, raw milk, and environmental water in Quebec, Canada. J Clin Microbiol (2008) 1.46

Swarming motility: a multicellular behaviour conferring antimicrobial resistance. Environ Microbiol (2008) 1.46

Airway inflammation and infection in congenital bilateral absence of the vas deferens. Am J Respir Crit Care Med (2003) 1.44

Cluster of erythromycin- and ciprofloxacin-resistant Campylobacter jejuni subsp. jejuni from 1999 to 2001 in men who have sex with men, Québec, Canada. Clin Infect Dis (2003) 1.40

Inhibitors of pathogen intercellular signals as selective anti-infective compounds. PLoS Pathog (2007) 1.38

Novel riboswitch ligand analogs as selective inhibitors of guanine-related metabolic pathways. PLoS Pathog (2010) 1.36

Plant antimicrobial agents and their effects on plant and human pathogens. Int J Mol Sci (2009) 1.35

Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis. Clin Infect Dis (2013) 1.34

The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation. Environ Microbiol (2010) 1.33

Improving the reproducibility of Pseudomonas aeruginosa swarming motility assays. J Basic Microbiol (2008) 1.30

Burkholderia pseudomallei, B. thailandensis, and B. ambifaria produce 4-hydroxy-2-alkylquinoline analogues with a methyl group at the 3 position that is required for quorum-sensing regulation. J Bacteriol (2008) 1.27

Homeostatic interplay between bacterial cell-cell signaling and iron in virulence. PLoS Pathog (2010) 1.22

Transcription of virulence factors in Staphylococcus aureus small-colony variants isolated from cystic fibrosis patients is influenced by SigB. J Bacteriol (2006) 1.20

Burkholderia diversity and versatility: an inventory of the extracellular products. J Microbiol Biotechnol (2007) 1.17

Gene expression in Pseudomonas aeruginosa swarming motility. BMC Genomics (2010) 1.15

Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo. FEMS Immunol Med Microbiol (2004) 1.13

Full virulence of Pseudomonas aeruginosa requires OprF. Infect Immun (2010) 1.12

Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol (2010) 1.10

The pathogenesis and control of Staphylococcus aureus-induced mastitis: study models in the mouse. Microbes Infect (2005) 1.09

Burkholderia thailandensis harbors two identical rhl gene clusters responsible for the biosynthesis of rhamnolipids. BMC Microbiol (2009) 1.08

MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline). PLoS One (2011) 1.05

Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection. BMC Infect Dis (2010) 1.04

3',5'-cyclic diguanylic acid reduces the virulence of biofilm-forming Staphylococcus aureus strains in a mouse model of mastitis infection. Antimicrob Agents Chemother (2005) 1.01

Zinc chelators inhibit eotaxin, RANTES, and MCP-1 production in stimulated human airway epithelium and fibroblasts. Am J Physiol Lung Cell Mol Physiol (2003) 1.00

c-di-GMP turn-over in Clostridium difficile is controlled by a plethora of diguanylate cyclases and phosphodiesterases. PLoS Genet (2011) 0.99

A role for sigma factor B in the emergence of Staphylococcus aureus small-colony variants and elevated biofilm production resulting from an exposure to aminoglycosides. Microb Pathog (2009) 0.98

High-resolution melting system to perform multilocus sequence typing of Campylobacter jejuni. PLoS One (2011) 0.98

PqsA is required for the biosynthesis of 2,4-dihydroxyquinoline (DHQ), a newly identified metabolite produced by Pseudomonas aeruginosa and Burkholderia thailandensis. Biol Chem (2007) 0.98

Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis. Foodborne Pathog Dis (2008) 0.97

Desketoneoenactin-siderophore conjugates for Candida: evidence of iron transport-dependent species selectivity. Antimicrob Agents Chemother (2005) 0.97

Laboratory diagnosis of Ebola virus disease. Intensive Care Med (2015) 0.96

Staphylococcus aureus SigB activity promotes a strong fibronectin-bacterium interaction which may sustain host tissue colonization by small-colony variants isolated from cystic fibrosis patients. Mol Microbiol (2008) 0.96

The fibronectin-binding proteins of Staphylococcus aureus may promote mammary gland colonization in a lactating mouse model of mastitis. Infect Immun (2003) 0.95

Vfm a new quorum sensing system controls the virulence of Dickeya dadantii. Environ Microbiol (2012) 0.92

Conserved virulence factors of Pseudomonas aeruginosa are required for killing Bacillus subtilis. J Microbiol (2005) 0.92

Tomatidine acts in synergy with aminoglycoside antibiotics against multiresistant Staphylococcus aureus and prevents virulence gene expression. J Antimicrob Chemother (2011) 0.92

Mouse mastitis model of infection for antimicrobial compound efficacy studies against intracellular and extracellular forms of Staphylococcus aureus. Vet Microbiol (2004) 0.92

Docosahexaenoic acid derivative prevents inflammation and hyperreactivity in lung: implication of PKC-Potentiated inhibitory protein for heterotrimeric myosin light chain phosphatase of 17 kD in asthma. Am J Respir Cell Mol Biol (2010) 0.91

The prostanoid 15-deoxy-Δ12,14-prostaglandin-j2 reduces lung inflammation and protects mice against lethal influenza infection. J Infect Dis (2012) 0.91

Phase variation has a role in Burkholderia ambifaria niche adaptation. ISME J (2009) 0.90

SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One (2013) 0.90

Lysosomotropic drugs inhibit maturation of transforming growth factor-beta. Can J Physiol Pharmacol (2008) 0.90

Identification and characterization of a novel CprA reductive dehalogenase specific to highly chlorinated phenols from Desulfitobacterium hafniense strain PCP-1. Appl Environ Microbiol (2010) 0.89

Transcriptional modulation of some Staphylococcus aureus iron-regulated genes during growth in vitro and in a tissue cage model in vivo. Microbes Infect (2006) 0.89

Growth performance and shedding of some pathogenic bacteria in feedlot cattle treated with different growth-promoting agents. J Food Prot (2006) 0.88

Drosophila melanogaster as a model host for the Burkholderia cepacia complex. PLoS One (2010) 0.88

Tomatidine inhibits replication of Staphylococcus aureus small-colony variants in cystic fibrosis airway epithelial cells. Antimicrob Agents Chemother (2011) 0.87

Antibiotic resistance and hypermutability of Escherichia coli O157 from feedlot cattle treated with growth-promoting agents. J Food Prot (2005) 0.87

Liquid chromatographic/mass spectrometric detection of the 3-(3-hydroxyalkanoyloxy) alkanoic acid precursors of rhamnolipids in Pseudomonas aeruginosa cultures. J Mass Spectrom (2002) 0.87

Evaluation of some Staphylococcus aureus iron-regulated proteins as vaccine targets. Vet Immunol Immunopathol (2010) 0.87

Comparison of antimicrobial resistance of Campylobacter jejuni isolated from humans, chickens, raw milk, and environmental water in Québec. J Food Prot (2007) 0.86

Antiapoptotic proteins Bcl-2 and Bcl-XL inhibit Clostridium difficile toxin A-induced cell death in human epithelial cells. Infect Immun (2009) 0.85

In vitro and in vivo antibacterial activities of cranberry press cake extracts alone or in combination with β-lactams against Staphylococcus aureus. BMC Complement Altern Med (2013) 0.85

Liquid chromatography/mass spectrometry for the detection and quantification of N-acyl-L-homoserine lactones and 4-hydroxy-2-alkylquinolines. Methods Mol Biol (2011) 0.85

Monorhamnolipids and 3-(3-hydroxyalkanoyloxy)alkanoic acids (HAAs) production using Escherichia coli as a heterologous host. Appl Microbiol Biotechnol (2006) 0.84

Invasiveness of breast cancer cells MDA-MB-231 through extracellular matrix is increased by the estradiol metabolite 4-hydroxyestradiol. Int J Cancer (2005) 0.84

Bacterial diversity of a consortium degrading high-molecular-weight polycyclic aromatic hydrocarbons in a two-liquid phase biosystem. Microb Ecol (2008) 0.84

Inflammatory cell infiltration as an indicator of Staphylococcus aureus infection and therapeutic efficacy in experimental mouse mastitis. Vet Immunol Immunopathol (2005) 0.83

The complex symbiotic relationships of bark beetles with microorganisms: a potential practical approach for biological control in forestry. Pest Manag Sci (2012) 0.83

Thermotolerant coliforms are not a good surrogate for Campylobacter spp. in environmental water. Appl Environ Microbiol (2009) 0.83

β-Amyloid peptides display protective activity against the human Alzheimer's disease-associated herpes simplex virus-1. Biogerontology (2014) 0.83

Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol. J Steroid Biochem Mol Biol (2003) 0.82

Identification of quorum sensing-controlled genes in Burkholderia ambifaria. Microbiologyopen (2013) 0.82

Infection of polarized airway epithelial cells by normal and small-colony variant strains of Staphylococcus aureus is increased in cells with abnormal cystic fibrosis transmembrane conductance regulator function and is influenced by NF-κB. Infect Immun (2011) 0.82

Relative cytotoxicity of Escherichia coli O157:H7 isolates from beef cattle and humans. Foodborne Pathog Dis (2009) 0.81

Optimization of furin inhibitors to protect against the activation of influenza hemagglutinin H5 and Shiga toxin. J Med Chem (2013) 0.81

Liquid chromatography/mass spectrometry for the identification and quantification of rhamnolipids. Methods Mol Biol (2014) 0.81

Anti-cancer effects of a new docosahexaenoic acid monoacylglyceride in lung adenocarcinoma. Recent Pat Anticancer Drug Discov (2013) 0.81

Vitamin C augments lymphocyte glutathione in subjects with ascorbate deficiency. Am J Clin Nutr (2003) 0.80